DC Linch

2.0k total citations
37 papers, 1.5k citations indexed

About

DC Linch is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, DC Linch has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in DC Linch's work include Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). DC Linch is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). DC Linch collaborates with scholars based in United Kingdom, United States and India. DC Linch's co-authors include G. Vaughan Hudson, B. Vaughan Hudson, KA MacLennan, Lori Anderson, A.M. Jelliffe, Peter Hoskin, B. W. Hancock, Peter Smith, KM Ardeshna and AJ Norton and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

DC Linch

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DC Linch United Kingdom 19 949 720 397 256 241 37 1.5k
Teodoro Chisesi Italy 17 972 1.0× 580 0.8× 552 1.4× 253 1.0× 414 1.7× 89 1.4k
Anne Lennard United Kingdom 20 831 0.9× 561 0.8× 562 1.4× 168 0.7× 240 1.0× 51 1.6k
C. Portlock United States 21 1.1k 1.1× 732 1.0× 438 1.1× 261 1.0× 219 0.9× 36 1.6k
Gabriella Pichert Switzerland 21 507 0.5× 541 0.8× 258 0.6× 172 0.7× 184 0.8× 46 1.5k
Cherie H. Dunphy United States 24 817 0.9× 683 0.9× 519 1.3× 215 0.8× 270 1.1× 127 2.0k
J. M. Vose United States 15 801 0.8× 596 0.8× 289 0.7× 198 0.8× 148 0.6× 34 1.2k
P. M. Kluin Netherlands 21 1.0k 1.1× 797 1.1× 431 1.1× 193 0.8× 314 1.3× 40 1.8k
Onsi W. Kamel United States 27 1.2k 1.2× 1.4k 1.9× 385 1.0× 231 0.9× 414 1.7× 46 2.5k
R I Fisher United States 21 1.2k 1.2× 787 1.1× 441 1.1× 300 1.2× 215 0.9× 40 1.6k
W S Velasquez United States 16 845 0.9× 670 0.9× 367 0.9× 238 0.9× 78 0.3× 17 1.3k

Countries citing papers authored by DC Linch

Since Specialization
Citations

This map shows the geographic impact of DC Linch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DC Linch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DC Linch more than expected).

Fields of papers citing papers by DC Linch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DC Linch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DC Linch. The network helps show where DC Linch may publish in the future.

Co-authorship network of co-authors of DC Linch

This figure shows the co-authorship network connecting the top 25 collaborators of DC Linch. A scholar is included among the top collaborators of DC Linch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DC Linch. DC Linch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomson, Kirsty, K Peggs, Patricia S. Smith, et al.. (2008). Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation. Bone Marrow Transplantation. 41(9). 765–770. 71 indexed citations
2.
Nolan, L., Paul Lorigan, James Newman, et al.. (2007). Low‐dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue. British Journal of Haematology. 137(5). 436–442. 5 indexed citations
3.
Yung, Lynny, Peter J. Smith, B. W. Hancock, et al.. (2004). Long Term Outcome in Adolescents with Hodgkin's Lymphoma: Poor Results using Regimens Designed for Adults. Leukemia & lymphoma. 45(8). 1579–1585. 15 indexed citations
4.
Ardeshna, KM, Peter Smith, AJ Norton, et al.. (2003). Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. The Lancet. 362(9383). 516–522. 366 indexed citations
5.
Morris, Emma, Charles Craddock, D Milligan, et al.. (2002). Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL).. UCL Discovery (University College London). 2 indexed citations
6.
Ardeshna, Kirit M., et al.. (2001). The long-term impact of a watch and wait policy vs immediate systemic treatment for asymptomatic advanced stage indolent non Hodgkins lymphoma: Results of a British national lymphoma randomised trial. UCL Discovery (University College London).
7.
8.
9.
Ahmed, Faheem, et al.. (2000). Poor viability of freshly apheresed PBSC harvests: Implications for overnight storage before cryopreservation or additional manipulative procedures.. UCL Discovery (University College London). 1 indexed citations
10.
Varsani, Hemlata, et al.. (2000). Immune reconstitution post autologous stem cell transplantation (ASCT) for paediatric vasculitis and resulting changes in autoimmune disease profile. UCL Discovery (University College London). 1 indexed citations
11.
12.
Barnett, David, Golding Bird, Emily Hodges, et al.. (1997). Guidelines for the enumeration of CD4+ T lymphocytes in immunosuppressed individuals. Clinical & Laboratory Haematology. 19(4). 231–241. 34 indexed citations
13.
Hancock, Barry W., G. Vaughan Hudson, B. Vaughan Hudson, et al.. (1994). Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: A prematurely terminated British National Lymphoma Investigation randomized trial. Annals of Oncology. 5. S117–S120. 3 indexed citations
14.
Hudson, B. Vaughan, G. Vaughan Hudson, DC Linch, & Lori Anderson. (1994). Late mortality in young BNLI patients cured of Hodgkin's disease. Annals of Oncology. 5. S65–S66. 23 indexed citations
15.
Gisselbrecht, Christian, G Prentice, Almalina Bacigalupo, et al.. (1993). A PHASE-III RANDOMIZED PLACEBO-CONTROLED STUDY IN 315 PEDIATRIC AND ADULT AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH LENOGRASTIM-5 UG/KG/DAY (GLYCOSYLATED RHU-G-CSF). UCL Discovery (University College London). 4 indexed citations
16.
Hancock, Barry W., G. Vaughan Hudson, B. Vaughan Hudson, et al.. (1992). LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial.. Journal of Clinical Oncology. 10(8). 1252–1258. 39 indexed citations
17.
Thomas, N S & DC Linch. (1991). An intracellular 50-kDa Fc gamma-binding protein is induced in human cells by alpha-IFN. The Journal of Immunology. 146(5). 1649–1654. 4 indexed citations
18.
Schey, Steve, B. Vaughan Hudson, DC Linch, et al.. (1989). The prognostic influence of mediastinal bulk in pathological stage IIA Hodgkin's disease treated initially with radiotherapy. Clinical Oncology. 1(1). 28–32. 2 indexed citations
19.
Bown, SG, et al.. (1987). PHTHALOCYANINE PHOTOSENSITIZATION FOR INVITRO ELIMINATION OF RESIDUAL ACUTE NONLYMPHOBLASTIC LEUKEMIA - PRELIMINARY EVALUATION. Photochemistry and Photobiology. 2 indexed citations
20.
Hudson, B. Vaughan, DC Linch, Elizabeth Macintyre, et al.. (1987). Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.. Journal of Clinical Pathology. 40(3). 247–250. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teodoro Chisesi Breakdown of academic impact, for papers by Anne Lennard Breakdown of academic impact, for papers by C. Portlock Breakdown of academic impact, for papers by Gabriella Pichert Breakdown of academic impact, for papers by Cherie H. Dunphy Breakdown of academic impact, for papers by J. M. Vose Breakdown of academic impact, for papers by P. M. Kluin Breakdown of academic impact, for papers by Onsi W. Kamel Breakdown of academic impact, for papers by R I Fisher Breakdown of academic impact, for papers by W S Velasquez
Rankless by CCL
2026